Before the new healthcare reform is finally unveiled, it is hard to predict the impact the medical industries Hill experience.
Before the new healthcare reform is finally unveiled, it is hard to predict the impact the medical industries Hill experience. It is certain, however, that the Chinese regulatory agencies will use regulations to further restrict the erosion of inferior products in the market. Pressures from the market, government policies and regulatory agencies Hill further push the restructuring of the industries, injecting more professional practice and ethical business relationships among the players. As the industry matures and technology and new products emerge, we can expect a healthy 14%-16% (at minimum) annual growth for the industry in the next five to 10 years.
Chang-Hong Whitney is president of Whitney Consulting Ltd. in Massachusetts. With an MBA from Babson College (Wellesley, MA) and undergraduate degrees in electronic engineering and international business, she has been consulting for western companies on doing business in China since 1994, focusing on the medical device market. Her services include China regulatory affairs, market research, sourcing and logistics programs and China business strategies. She can be reached at email@example.com.
|Printer friendly Cite/link Email Feedback|
|Title Annotation:||China News|
|Publication:||Medical Product Outsourcing|
|Date:||Jan 1, 2008|
|Previous Article:||Want to know China's future? Look back at policy changes of the past year.|
|Next Article:||AngioDynamics reports 70% jump in Q2 net sales.|